We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Documents relating to the independent review led by Bridget Rosewell OBE.
Actions that trial sponsors should consider to build resilience into clinical trial design
Investors and businesses may be legally required to tell the government about certain sensitive acquisitions under the National Security and Investment Act.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Find out when and how to appeal if Natural England refuses you consent to carry out an activity on a site of special scientific interest.
A guide for operators and the public about regulatory hearings held by traffic commissioners, known as ‘public inquiries’.
This Privacy Notice explains who is processing your data, the personal data we collect, how we use it, who we share it with, and what your legal rights are.
How to contact MHRA for specific services or enquiries.
Inquiring into all the circumstances surrounding allegations of unlawful killing by British Forces.
A Guide for Employers and Employees to the role of the Central Arbitration Committee (CAC) for these regulations
Find out about employment related securities scheme reporting requirements.
Reports and reviews relating to substance misuse.
Apply to set up an arrangement with your employer to be kept informed and to be consulted
How investigators and sponsors should manage clinical trials during COVID-19
Guidance on regulations covering new power generating plants and wayleaves.
This document sets out the aims of the public inquiry into the coronavirus (COVID-19) pandemic.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Guidance explaining why compulsory purchase orders are made, and what people's rights are to challenge them.
Guidance on obtaining consent for development of energy infrastructure: overhead lines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).